Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

Novel Non-Fentanyl Synthetic Opioids: Risk Assessment and Implications for Practice

Given the need for effective responses of the health system to reduce substance-related harms, it is important to consider the potential impact of novel non-fentanyl synthetic opioids on opioid-rel

Report | 2021

Illegal drugs, Drug checking, Harm reduction

Focus on: Safe Supply - Findings from Focus Groups with People Who Use Unregulated Drugs

Use focus groups to explore the idea of safe supply with PWUD

Report | 2019

Evidence base, Harm reduction, Safer supply, About PWUD, Peer/PWLLE program involvement, Sex/Gender

Cool Aid Community Health Centre Report on Risk Mitigation Guidance Prescriptions: Providing “Safer Supply” in CAMICO Sheltering Sites, Outreach and Primary Care Practice

The primary aims of this report were to: 1. Describe the RMG program at the CACHC; 2. Describe the characteristics of clients participating in RMG through the CACHC; 3.

Report | 2020

Overdose, Evidence base, Harm reduction, Policy/Regulatory, Wrap-around services, Safer supply, Advocacy, About prescribers, Outcomes, Housing, Youth, Chronic pain

Drug Decriminalisation in Portugal: Setting the Record Straight

Update on the effects of Portugal's drug decriminalization policy

Report | 2021

Mortality, Policy/Regulatory, Decriminalization/legalization, Outcomes, Crime

Reducing Drug Users' Risk of Overdose

Research project looking at ways of reducing drug users’ risk of overdose, conducted on behalf of the Scottish Government.

Report | 2008

Overdose, Harm reduction, About pharmacists, About prescribers, Social services, Legal system/law enforcement

Matériel d’injection : réduire les risques chez les injecteurs de médicaments opioïdes

Recommend best injection practices to reduce infections, while keeping risk in mind

Report | 2015

Harm reduction, Policy/Regulatory, Safer supply, Injecting drugs, SCS/OPS

Community based low threshold substance use services: Practitioner approaches and challenges

To explore the efficacy and challenges of delivering low threshold substance use services within a community setting, with particular consideration of practitioner approaches

Report | 2016

Evidence base, Wrap-around services, About prescribers, Social services, Barriers and enablers, Outcomes

Portrait du matériel d'injection et d'inhalation de drogues remis par les directions de santé publique aux centres d'accès du Québec : 2016-2017 à 2018-2019

Présente une analyse comparative des quantités de matériel remis par les directions de santé publique aux 1 239 centres d’accès au matériel d’injection.

Report | 2021

Harm reduction, Outcomes, Illegal drugs, Social benefits

Saving Lives. Changing Lives. Findings from an Evaluation of London’s Temporary Overdose Prevention Site (TOPS)

Process and outcome evaluation of the site's first six months

Report | 2019

Overdose, Harm reduction, Wrap-around services, Advocacy, About prescribers, About PWUD, Social services, Barriers and enablers, Outcomes, Crime, Illegal drugs, Drug checking, Stigma, SCS/OPS

Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States

Given the severity of the opioid crisis, there is urgency to evaluate tools that might reduce its impact and save lives.

Report | 2018

Overdose, Harm reduction, Policy/Regulatory, Safer supply, SCS/OPS

The Global Drug Policy Index 2021 - Analytical report

The Global Drug Policy Index is a unique tool that documents, measures and compares national-level drug policies, providing each country with a score and ranking that shows how much their drug policie

Report | 2021

Policy/Regulatory, Equity

Changing Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic

Update data from the 2020 preliminary report on opioid-related deaths before and during the pandemic

Report | 2021

Overdose, Mortality, Evidence base, Advocacy, Housing, Illegal drugs, Workplace, Rural/remote, Stimulants, Sex/Gender

Heroin Assisted Treatment: The state of play

This briefing paper explores the question of Heroin Assisted Treatment (HAT), examines the growing body of evidence emerging from its clinical use in addiction therapies, and makes recommendations for

Report | 2010

Evidence base, Policy/Regulatory, Advocacy

Preliminary Patterns in Circumstances Surrounding Opioid-Related Deaths in Ontario during the COVID-19 Pandemic

Examination of suspected opioid-related deaths in Ontario before and during the pandemic

Report | 2020

Overdose, Mortality, Evidence base, Safer supply, Advocacy, Social services, Poverty, Housing, Illegal drugs, Sex/Gender

Canadian Pain Task Force Report: March 2021

Report | 2021

Overdose, Harm reduction, Policy/Regulatory, Equity, Advocacy, About prescribers, About PWUD, Legal system/law enforcement, Illegal drugs, Youth, Chronic pain, Workplace, 2SLGBTQI+, Indigenous, Sex/Gender , Mental health

Research 101: A Manifesto for Ethical Research in the Downtown Eastside

This manifesto builds on, and complements, the work of many other DTES organizations to empower themselves in setting up more equitable and ethical partnerships with researchers.

Report | 2019

About PWUD, Peer/PWLLE program involvement